Target intelligence / Profile preview

Vascular smooth muscle cell (peripheral artery) (VSMC)

Target
VSMC
Molecular classification
Other (cell type/tissue, not a single molecular family)
01

Overview

Peripheral arterial smooth muscle refers to the smooth muscle cells predominantly located in the medial layer of peripheral arteries. These cells are essential for vessel contraction and relaxation, regulating blood flow and blood pressure. VSMCs show plasticity, switching phenotypes in response to injury or disease, and play central roles in vascular remodeling, arterial stiffness, calcification, and the pathogenesis of cardiovascular diseases such as hypertension, atherosclerosis, and peripheral artery disease. Drugs exert therapeutic effects on the vasculature by acting on molecular targets within these cells. In summary, "peripheral arterial smooth muscle" is a tissue/cell population, not a canonical molecular or receptor target. For pharmacological or structured data purposes, the specific molecule or receptor of interest (such as "L-type calcium channel, alpha-1C subunit," or "angiotensin II receptor type 1") should be used instead.

Other names
vascular smooth muscle cellarterial smooth muscleVSMCsmooth muscle cell of artery
02

Mechanism of action

None specific (see above — drugs act via targets in VSMCs: e.g., Ca2+ channel blocking leads to vasodilation; angiotensin receptor antagonism reduces vasoconstriction)

03

Biological functions

Regulation of vessel diameter and vascular toneControl of blood pressure and tissue perfusionVascular remodeling, including phenotypic switching in disease statesResponse to injury and participation in inflammation, migration, proliferation, and extracellular matrix production
04

Disease associations

Cardiovascular disease (including atherosclerosis, hypertension, restenosis, peripheral artery disease)Vascular calcification and remodelingOther (role in systemic diseases with vascular components)
05

Safety considerations

Not directly applicable (as a tissue, not a druggable target; but drugs affecting VSMCs can cause hypotension, vascular spasm, etc.)

Beyond the preview

Go deeper on Vascular smooth muscle cell (peripheral artery) (VSMC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular smooth muscle cell (peripheral artery) (VSMC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call